Actively Recruiting
PEDAL-HF Study on Heart Failure Progression Randomized Trial Comparing Heart Failure Network Care Versus Usual Care Including Patients with Acute Decompensated Heart Failure
Led by University of Leipzig · Updated on 2026-05-06
1000
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating heart failure treatment approaches in patients recently hospitalized with acute decompensated heart failure. This prospective multicenter study aims to understand how care within a heart failure network compares to usual care, focusing on changes in NT-proBNP levels over six months. The study also follows all patients for two years to gather longer-term data. Participants will be divided into groups one receiving heart failure network care involving three visits with a cardiologist or heart failure clinic within three months after hospital discharge, and another receiving usual care from their primary physician or cardiologist. Patients who choose not to be randomized will be followed in a registry. The heart failure network care is designed to improve heart failure therapy during the vulnerable post-discharge period. During the study, participants will have follow-up visits and assessments including NT-proBNP blood tests at baseline and six months. Researchers will also evaluate quality of life changes using the Kansas City Cardiomyopathy Questionnaire KCCQ. All patients, whether randomized or not, will be monitored for two years to track health outcomes and treatment effects. The study started in November 2024 and will continue until December 2028.
CONDITIONS
Brief Title
Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study
Research Team
R
Rolf Wachter, MD
S
Sophie Charlotte Schröder, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here